Skip to Main Content
An official website of the United States government

Approved PLCO Projects

Here you can browse the complete list of projects for PLCO whose requests for data/biospecimens were approved.

Filter results of approved projects table below

Approved Projects
Name Principal Investigator Institution Study Date Approved Project ID
Effect of bilater salpingo-oophorectomy on morbidity and mortality Amanda Black NCI, DCEG, EBP PLCO Mar 14, 2013 PLCO-19
Second Cancers Following Radiotherapy in Prostate Cancer Patients in the PLCO Amanda Black NCI, DCEG, EBP PLCO Mar 14, 2013 PLCO-18
Biliary Tract Cancers Pooling Project Jill Koshiol NCI, DCEG, IIB PLCO Mar 5, 2013 PLCO-17
Genetic Targeted Screening Prediction of Prostate Cancer Mortality A. Karim Kader University of California, San Diego PLCO Mar 5, 2013 PLCO-14
Evaluation of serum antibodies to Helicobacter pylori proteins and hepatobiliary cancers Gwen Murphy Imperial College London PLCO Mar 4, 2013 2013-0035
Genome wide epigenetic alteration study to identify biomarkers of smoking and bladder cancer risk Lee Moore NCI, DCEG, OEEB PLCO Mar 4, 2013 2013-0033
Anti-Mullerian Hormone and Prostate Cancer Risk Martha Sklavos NCI, DCEG, IIB PLCO Mar 4, 2013 2013-0008
Prostate Specific Antigen (PSA) Growth Curves: an Innovation to Improve Prostate Cancer Screening James Hebert University of South Carolina, Cancer Prevention and Control Program PLCO Feb 22, 2013 PLCO-15
Impact of Family History on Colorectal Cancer Incidence and Expression Robert Schoen University of Pittsburgh PLCO Jan 25, 2013 PLCO-13
Calcium intake and lung cancer: effect modification by sex and smoking status Yumie Takata Vanderbilt University PLCO Jan 24, 2013 PLCO-11
Mortality and Morbidity Following Prostate Biopsy Paul Pinsky NCI, DCP, EDRG PLCO Jan 17, 2013 PLCO-12
Cancer history and melanoma risk Sonja Berndt NCI, DCEG, OEEB PLCO Dec 13, 2012 PLCO-10
Analysis of PSA, biopsy uptake predictive value and associated death in a prostate cancer screening programme Mathieu Boniol International Prevention Research Institute PLCO Dec 11, 2012 PLCO-8
Reconciling results of PSA screening efficacy using PLCO and ERSPC data: CISNET modeling project Ruth Etzioni Fred Hutchinson Cancer Research Center PLCO Dec 11, 2012 PLCO-9
BMI and risks of pancreatic cancer and multiple myeloma mortality in the African American BMI Pooling Project Cari Kitahara NCI, DCEG, NEB PLCO Dec 7, 2012 PLCO-7
Validation of a Risk Assessment Decision Rule for Epithelial Ovarian Cancer Nicole Urban Fred Hutchinson Cancer Research Center PLCO Dec 3, 2012 PLCO-6
Demographic, lifestyle, reproductive, and hormonal factors, medical history, and medication use in relation to thyroid cancer risk in the PLCO study Melissa Braganza NCI, DCEG, REB PLCO Nov 20, 2012 PLCO-5
Demographic, lifestyle, reproductive, and hormonal factors, medical history, and medication use in relation to glioma in the PLCO study Melissa Braganza NCI, DCEG, REB PLCO Nov 20, 2012 PLCO-4
Benign breast and reproductive conditions and thyroid cancer Melissa Braganza NCI, DCEG, REB PLCO Nov 20, 2012 PLCO-2
follow-up of abnormal CA 125 levels in patients in the PLCO trial Keith Terada University of Hawaii PLCO Nov 14, 2012 PLCO-3